Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Oral Candidiasis Clinical Trials

A listing of Oral Candidiasis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (3) clinical trials

Candidemia is an infection of the blood caused by the fungus, Candida. The study drug, CD101, is being studied to treat candidemia. This is the first research study in which CD101 will be given to patients with candidemia. CD101 is an experimental or investigational drug. In this research study, CD101 ...

Phase

Open-Label Study to Evaluate Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Refractory or Intolerant Fungal Diseases

This is a multicenter, open label, non-comparator, single arm study to evaluate the efficacy and safety of SCY-078 in patients 18 years of age with a documented invasive and/or severe fungal disease that has been intolerant or refractory (rIFI) to Standard of Care (SoC) antifungal treatment. Patients will be treated ...

Phase

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)

This is a multicenter, open-label, non-comparator, single-arm study to evaluate the efficacy, safety, tolerability and PK (for a subset of subjects) of oral SCY-078 in male and female subjects 18 years of age with a documented Candida auris infection. Patients will be treated with SCY-078 for up to 90 days. ...

Phase